1-2 of 2
Fiona Loschi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Maintenance Therapy with Venetoclax/Azacitidine Can be Safely Given after Venetoclax/FluBu2 RIC Allogeneic Transplantation for the Treatment of High Risk MDS/AML: Results of a Phase 1 Study

Jacqueline S. Garcia, Haesook T Kim, Jennifer Brock, H. Moses Murdock, Corey S. Cutler, Daniel J. DeAngelo, Christopher J. Gibson, Mahasweta Gooptu, Vincent Ho, John Koreth, Marlise R. Luskin, Sarah Nikiforow, Rizwan Romee, Roman M Shapiro, Richard M. Stone, Martha Wadleigh, Eric S. Winer, Michela Ansuinelli, Eliza Elliot, Geoffrey Fell, Hannah Karp, Jeremy Ryan, Anthony G. Letai, Coleman Lindsley, Robert J Soiffer, Joseph H. Antin, Fiona Loschi, Jerome Ritz
Journal: Blood
Blood (2022) 140 (Supplement 1): 917–919.
https://doi.org/10.1182/blood-2022-157611
Published: 2022
Journal Articles

Safety and Efficacy of Adding Venetoclax to Reduced Intensity Conditioning Chemotherapy Prior to Allogeneic Hematopoietic Cell Transplantation in Patients with High Risk Myeloid Malignancies

Jacqueline S. Garcia, MD, Haesook Kim, Corey Cutler, MD MPH, FRCPC, Eric S. Winer, MD, Richard M. Stone, MD, Vincent T. Ho, MD, Rizwan Romee, MD, John Koreth, MBBS, DPhil, Mahasweta Gooptu, MD, Sarah Nikiforow, MD PhD, Roman M Shapiro, MD, David P. Steensma, MD, Marlise R. Luskin, MD, Martha Wadleigh, MD, Fiona Loschi, Jeremy Ryan, Anthony Letai, R. Coleman Lindsley, MD PhD, Jennifer Brock, Robert J. Soiffer, MD, Daniel J. DeAngelo, MD PhD, Joseph H. Antin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-134947
Published: 2020